SEC Form 4 · accession 0001193125-26-292962
Pharvaris N.V. · PHVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Jun 29, 2026
Accepted (ET)
Jul 1, 2026 · 7:06 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001830487
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 29, 2026 | S | 6,888 | $35.0533 | D | 345,879 | D | |
| Common StockF3 | Jun 30, 2026 | S | 30,712 | $35.4926 | D | 315,167 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This is a scheduled sale from 10b5-1 trading plan.
- F2The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The sales prices for the transactions ranged from $35.00 to $35.10 The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F3The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The sales prices for the transactions ranged from $35.00 to $35.90. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.